Omnicell PE Ratio 2010-2024 | OMCL

Current and historical p/e ratio for Omnicell (OMCL) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Omnicell PE ratio as of January 07, 2025 is 67.15.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Omnicell PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-01-06 44.71 0.00
2024-09-30 43.60 $-0.39 0.00
2024-06-30 27.07 $-0.46 0.00
2024-03-31 29.23 $-0.46 0.00
2023-12-31 37.63 $-0.76 0.00
2023-09-30 45.04 $-0.07 0.00
2023-06-30 73.67 $0.01 7367.00
2022-12-31 50.42 $0.10 504.20
2022-09-30 87.03 $1.02 85.32
2022-06-30 113.75 $0.32 355.47
2022-03-31 129.49 $0.73 177.38
2021-12-31 180.44 $0.99 182.26
2023-03-31 58.67 $1.01 58.09
2021-09-30 148.43 $1.71 86.80
2021-06-30 151.45 $1.30 116.50
2021-03-31 129.87 $0.77 168.66
2020-12-31 120.02 $0.73 164.41
2020-09-30 74.66 $0.87 85.82
2020-06-30 70.62 $1.13 62.50
2020-03-31 65.58 $1.60 40.99
2019-12-31 81.72 $1.42 57.55
2019-09-30 72.27 $1.27 56.91
2019-06-30 86.03 $1.14 75.46
2019-03-31 80.84 $0.93 86.92
2018-12-31 61.24 $0.92 66.57
2018-09-30 71.90 $1.18 60.93
2018-06-30 52.45 $1.01 51.93
2018-03-31 43.40 $0.87 49.89
2017-12-31 48.50 $0.51 95.10
2017-09-30 51.05 $-0.11 0.00
2017-06-30 43.10 $-0.22 0.00
2017-03-31 40.65 $-0.27 0.00
2016-12-31 33.90 $0.01 3390.00
2016-09-30 38.30 $0.22 174.09
2016-06-30 34.23 $0.39 87.77
2016-03-31 27.87 $0.66 42.23
2015-12-31 31.08 $0.84 37.00
2015-09-30 31.10 $0.88 35.34
2015-06-30 37.71 $0.86 43.85
2015-03-31 35.10 $0.83 42.29
2014-12-31 33.12 $0.83 39.90
2014-09-30 27.33 $0.77 35.49
2014-06-30 28.71 $0.78 36.81
2014-03-31 28.62 $0.74 38.68
2013-12-31 25.53 $0.67 38.10
2013-09-30 23.68 $0.64 37.00
2013-06-30 20.55 $0.63 32.62
2013-03-31 18.88 $0.50 37.76
2012-12-31 14.87 $0.47 31.64
2012-09-30 13.90 $0.43 32.33
2012-06-30 14.64 $0.32 45.75
2012-03-31 15.21 $0.36 42.25
2011-12-31 16.52 $0.31 53.29
2011-09-30 13.78 $0.21 65.62
2011-06-30 15.59 $0.16 97.44
2011-03-31 15.24 $0.14 108.86
2010-12-31 14.45 $0.15 96.33
2010-09-30 13.08 $0.15 87.20
2010-06-30 11.69 $0.14 83.50
2010-03-31 14.03 $0.11 127.55
2009-12-31 11.69 $0.02 584.50
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.053B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.669B 176.81
Hims & Hers Health (HIMS) United States $5.506B 140.00
Tempus AI (TEM) United States $5.393B 0.00
IRhythm Technologies (IRTC) United States $2.799B 0.00
Enovis (ENOV) United States $2.475B 16.78
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Fulgent Genetics (FLGT) United States $0.563B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Precipio (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00